You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

685 Results
Drug
Nov 2024
Drug
Other Name(s): Treanda®
Nov 2024
Drug
Other Name(s): Perjeta®
Sep 2022
Drug
Other Name(s): Adcetris®
Jun 2025
Drug
Other Name(s): Pomalyst®
Apr 2025
Drug
Other Name(s): Bosulif®
Nov 2024
Drug
Other Name(s): Blincyto®
Nov 2025
Drug
Other Name(s): Ibrance™
Oct 2025
Regimen
Cancer Type:
Central Nervous System
Intent: Adjuvant, Curative, Palliative
Funding:
ODB - General Benefit
    procarbazine
ODB - General Benefit
    lomustine
Jan 2023
Regimen
Cancer Type:
Genitourinary, 
Testis
Intent: Adjuvant, Curative
May 2019
Regimen
Cancer Type:
Genitourinary, 
Testis
Intent: Adjuvant, Curative
May 2019
Regimen
Cancer Type:
Central Nervous System
Intent: Palliative
Jul 2024

Pages